Netherton-Syndrom-Markt – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00013771
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 76
Buy Now

Der Markt für das Netherton-Syndrom wurde 2019 auf 19,57 Millionen US-Dollar geschätzt und soll bis 2027 74,31 Millionen US-Dollar erreichen; Es wird erwartet, dass sie von 2020 bis 2027 mit einer jährlichen Wachstumsrate von 20,3 % wachsen wird.



Das Netherton-Syndrom ist eine seltene Erkrankung, die durch Trichorrhexis invaginata, atopische Diathese und ichthyosiforme Erythrodermie gekennzeichnet ist. Die Trichorrhexis invaginata weist auf kurzes und brüchiges Haar hin, die atopische Diathese weist auf eine Anfälligkeit für Allergieprobleme hin, während die ichthyosiforme Erythrodermie rote, entzündete, schuppige Haut umfasst. Das Netherton-Syndrom ist erblich bedingt, da es ein autosomal-rezessives Merkmal ist. Die Krankheit wird hauptsächlich durch Mutationen im SPINK5-Gen verursacht. In einigen Fällen tritt das Syndrom auch auf, wenn zwei gesunde Eltern, die Träger des mutierten rezessiven Gens sind, ein Kind haben, das beide Kopien des rezessiven Gens erhält, auch wenn die Krankheit in der Familie nicht bekannt ist. Der Netherton-Syndrom-Markt verzeichnet ein enormes Wachstum aufgrund des zunehmenden Bewusstseins für das Netherton-Syndrom und der wachsenden Zahl von Produkteinführungen. Darüber hinaus bieten die steigende Zahl klinischer Studien und die robuste Produktpipeline erhebliche Chancen für das zukünftige Wachstum der Marktteilnehmer. Allerdings hemmt das Risiko von Nebenwirkungen im Zusammenhang mit den Medikamenten zur Behandlung des Netherton-Syndroms das Wachstum des Marktes.



Lukrative Regionen im globalen Netherton-Syndrom-Markt



Markteinblicke



Zunehmende Zahl von Aufklärungskampagnen zum Netherton-Syndrom, um das Wachstum voranzutreiben



Das Netherton-Syndrom ist eine autosomal-rezessiv vererbte seltene Hauterkrankung, die Haare, Haut und das Immunsystem beeinträchtigt. Die Krankheit betrifft meist Neugeborene, bei denen die Haut meist gerötet und schuppig ist und in manchen Fällen auch Flüssigkeit austritt. Patienten, die an dieser Erkrankung leiden, sind sich der verfügbaren Behandlungsmöglichkeiten in der Regel nicht bewusst und haben keinen einfachen Zugang und keine ausreichenden Informationen über die zu ergreifende Pflege. Sensibilisierungskampagnen sind wirkungsvoll, da sie eine zeitnahe und genaue Diagnose ermöglichen. Daher arbeiten verschiedene medizinische und soziale Organisationen daran, das Bewusstsein zu schärfen und den Patienten mit Netherton-Syndrom auf der ganzen Welt zu helfen.



Foundation for Ichthyosis& Related Skin Types (FIRST) hat in Zusammenarbeit mit dem National Health Council (NHC) eine Organisation gegründet, die sich zum Ziel gesetzt hat, das Leben von Patienten zu verbessern und nach Heilmitteln zu suchen, die von Ichthyose und verwandten Hauttypen betroffen sind. Die Organisation stellt genaue und zeitnahe Informationen zum Netherton-Syndrom und zur Ichthyose bereit, die den Patienten helfen, den sozialen, medizinischen und pädagogischen Bedürfnissen der Krankheitsgemeinschaft gerecht zu werden. Darüber hinaus hat sich die Ichthyosis Support Group (ISG) zum Ziel gesetzt, die Gesundheit zu schützen und zu erhalten und Patienten zu entlasten, die von Ichthyose und anderen damit verbundenen Erkrankungen betroffen sind. Die ISG stellt Informationspakete bereit, verteilt Bulletins und Newsletter, organisiert Wohnlager für Kinder und anderes. Daher wird erwartet, dass die Sensibilisierungskampagnen und Programme zur Information der Patienten und anderer Menschen über das Netherton-Syndrom das Wachstum des Marktes in den kommenden Jahren steigern werden.

Therapiebasierte Erkenntnisse



Basierend auf der Therapie ist der globale Netherton-Syndrom-Markt in Keratolytika, orale und topische Steroide und Retinoide, topische Calcineurin-Inhibitoren, biologische Therapien und Strahlentherapien unterteilt. Im Jahr 2019 hielt das Segment der Keratolytika den größten Marktanteil. Das Wachstum dieses Segmentmarktes ist auf die zunehmenden Produkteinführungen und die robuste bestehende Produktpipeline zurückzuführen. Darüber hinaus beschleunigen strategische Aktivitäten von Dienstleistern wie Kooperationen, Fusionen und Übernahmen sowie Erweiterungen zur Beschleunigung der Arzneimittelzeitplanung das Wachstum des Marktes weiter. Es wird jedoch erwartet, dass das Segment der biologischen Therapie im Zeitraum 2020–2027 die höchste CAGR im globalen Netherton-Syndrom-Markt verzeichnen wird.



Netherton-Syndrom-Markt, nach Therapie – 2019 und 2027



Strategische Einblicke



Produkteinführungen und Forschungskooperationen sind die gängigsten Strategien von Unternehmen, um ihre Präsenz weltweit auszubauen und der wachsenden Verbrauchernachfrage gerecht zu werden. Die Marktteilnehmer des Netherton-Syndroms haben die Strategie der Produktinnovationen übernommen, um auf die sich ändernde Kundennachfrage auf der ganzen Welt einzugehen, was ihnen auch ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.



Markt für Netherton-Syndrom – nach Therapie



< ul>
  • Keratolytische Wirkstoffe

  • Orale und topische Steroide und Retinoide

  • Topische Calcineurin-Inhibitoren

  • Strahlentherapien

  • Biologische Therapien

    Netherton-Syndrom-Markt – nach Geografie




    • Nordamerika

      • USA



    • Europa

      • Frankreich

      • Deutschland

      • Italien

      • Großbritannien

      • Spanien


    • Asien-Pazifik (APAC)

      • Japan




    Unternehmensprofile




    • Lifemax Laboratories, Inc.

    • Azitra, Inc.

    • Sixera Pharma Ab

    • Dermelix Biotherapeutics

    • Matrisys Bioscience

    • Quoin Pharmaceuticals Ltd.

    • Krystal Biotech, Inc.


  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is Netherton syndrome?

    Netherton syndrome is a rare genetic disorder that presents the three following characteristics: Ichthyosiform erythroderma, a red, inflamed, scaly skin. Trichorrhexis invaginata – short, brittle, lustreless hair, Atopic diathesis – predisposition to allergy problems. Netherton syndrome is inherited as an autosomal recessive trait disease. The NS condition is caused by mutations in the SPINK5 gene that is found on the chromosome. In some cases, there is no family history of the disease. NS is revealed when two unaffected parents (recessive) and both are carriers of the mutated recessive gene have a child who receives both copies of the recessive gene.

    What are the driving factors for the Netherton syndrome market across the globe?

    The factors that are driving growth of the market are increasing number of Netherton syndrome awareness campaigns and growing number of product launches with robust pipeline. Moreover, strategic activities by the manufacturers are offering lucrative opportunities for the growth of the market.

    Who are the major players in the Netherton syndrome market?

    The Netherton syndrome market majorly consists of the players such as Lifemax Laboratories, Inc., Azitra, Inc., Sixera Pharma Ab, Dermelix Biotherapeutics, Matrisys Bioscience, Quoin Pharmaceuticals Ltd., and Krystal Biotech, Inc. among others.

    The List of Companies - Netherton Syndrome Market

    1. Lifemax Laboratories, Inc.
    2. Azitra, Inc.
    3. Sixera Pharma Ab
    4. Dermelix Biotherapeutics
    5. Matrisys Bioscience
    6. Quoin Pharmaceuticals Ltd.
    7. Krystal Biotech, Inc

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports